You are viewing: North America Poultry Diagnostics Market analysis
Part of: Poultry Diagnostics Market (Global)

The North America Poultry Diagnostics Market was valued at $76.7 Million in 2026 and projected to reach to $107 Million by 2031, representing a compound annual growth rate of 6.9%. North America's poultry diagnostics market is experiencing robust growth fueled by increasingly stringent regulatory frameworks and heightened biosecurity awareness among producers.

North America Poultry Diagnostics Market (2026-2031) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

North America Poultry Diagnostics Market Trends and Insights

  • In North America, the expansion is driven by stringent biosecurity regulations, increasing disease surveillance requirements, and rising adoption of advanced diagnostic technologies across commercial poultry operations.
  • North America's market benefits from well-established veterinary infrastructure and significant investment in animal health innovation. The forecast period from 2026 to 2031 reflects North America's commitment to preventing avian diseases and maintaining flock health through rapid diagnostic solutions.
  • In North America, key drivers include the consolidation of poultry production, heightened consumer demand for safe poultry products, and integration of molecular and immunological diagnostic platforms.
  • North America continues to lead in adopting point-of-care and laboratory-based diagnostic systems to enhance operational efficiency and disease management..

Key Market Statistics

  • CAGR (2026-2031) 6.9% CAGR
  • Market Size, 2026 ~USD 76.7 Million
  • Forecast, 2031 ~USD 107 Million
  • Geography North America

North America Poultry Diagnostics Market Overview

Regulatory Compliance Driving Growth :

Stringent biosecurity regulations and mandatory disease surveillance requirements across the US and Canada are compelling commercial poultry producers to invest in advanced diagnostic solutions, creating sustained market demand.

US Market Dominance :

The United States accounts for the majority of North America's poultry diagnostics market at $104.72 million, driven by large-scale commercial operations and high adoption of automated diagnostic technologies.

Technology Adoption Acceleration :

Rising adoption of molecular diagnostics, PCR-based testing, and real-time monitoring systems across North American poultry farms is enhancing disease detection speed and operational efficiency.

Projected Growth Trajectory :

The North American market is expected to grow from $76.7 million in 2026 to $107.0 million by 2031, representing a 6.9% CAGR, outpacing global growth in select segments.

North America Poultry Diagnostics Market Dynamics

  • The region's mature commercial poultry industry, particularly in the United States, is rapidly adopting advanced diagnostic technologies to ensure flock health and prevent disease outbreaks.
  • Investment in preventive diagnostics is becoming standard practice rather than reactive measure. Looking ahead to 2031, the market will be shaped by continued regulatory tightening, integration of digital health monitoring platforms, and growing demand for rapid, on-farm diagnostic solutions.
  • The expansion of poultry production capacity and rising consumer demand for safe poultry products will further accelerate diagnostic technology adoption across North America's commercial and emerging farm segments..

Related Ecosystem

Animal Health

Top Technologies
  • Polymerase Chain Reaction (PCR) Tests
  • Porcine
  • Immunodiagnostics
  • Lateral Flow Assays
  • Microarrays
Top Companies
  • Zoetis Inc.
  • Patterson Companies, Inc.
  • Virbac
  • Elanco Animal Health Incorporated
  • BOEHRINGER INGELHEIM GMBH

    Key Takeaways

    • North America's poultry diagnostics market will grow from $76.7M (2026) to $107.0M (2031) at a 6.9% CAGR.
    • North America's regulatory environment and biosecurity standards drive demand for advanced diagnostic solutions.
    • North America is experiencing increased adoption of molecular and rapid diagnostic technologies in commercial poultry operations.
    • North America's well-developed veterinary infrastructure supports market expansion and innovation in disease detection.

    Poultry Diagnostics Market Report Scope

    Report Metric Details
    Base Year 2026
    Fastest Growing Segment AVIAN INFLUENZA (Disease Type)
    Forecast Period 2026–2031
    Growth Rate CAGR of 7.1% from 2026 to 2031
    Largest Segment CONSUMABLES & REAGENTS (Product Type)
    Market Size Base Year (Billions) ~USD 0.18 (2026)
    Revenue Forecast (Billions) ~USD 0.25 (2031)
    Segments Covered Product Type, Type, Test Type, Disease Type, Poultry Type, Sample Type, End User

    North America Poultry Diagnostics Market Report Segmentation

    7 segment dimensions are covered across the global market.

    By Product Type

    • Consumables & Reagents
    • Instruments

    By Type

    • Avian Influenza Elisa Tests
    • Avian Influenza Pcr Panels
    • Bacterial Elisa Tests
    • Bacterial Pcr Panels
    • Controls & Laboratory Consumables
    • Elisa Kits & Reagents
    • Elisa Readers & Washers
    • Endemic Viral Elisa Tests
    • Endemic Viral Pcr Panels
    • Mycoplasma Elisa Tests
    • Mycoplasma Pcr Panels
    • Newcastle Disease Elisa Tests
    • Newcastle Disease Pcr Panels
    • Nucleic Acid Extraction Systems
    • Other Laboratory Automation Instruments
    • Pcr Instruments
    • Pcr Kits & Reagents
    • Sample Preparation & Extraction Kits

    By Test Type

    • Elisa-Based Diagnostics
    • Other Diagnostic Tests
    • Pcr-Based Diagnostics

    By Disease Type

    • Avian Influenza
    • Avian Mycoplasmosis
    • Infectious Bronchitis
    • Infectious Bursal Disease (Ibd)
    • Newcastle Disease
    • Other Infectious Diseases
    • Salmonellosis

    By Poultry Type

    • Breeders
    • Broilers
    • Ducks & Geese
    • Layers
    • Other Poultry
    • Turkeys

    By Sample Type

    • Environmental & Fecal Samples
    • Serum/Blood
    • Swabs
    • Tissue Samples

    By End User

    • Academic & Research Institutions
    • Government & Reference Laboratories
    • Integrated Poultry Producers
    • Other Specialized Laboratories
    • Veterinary Diagnostic Laboratories

    Target Audience

    • Poultry Producers & Integrators : Commercial poultry operations need this data to understand diagnostic technology investment requirements, regulatory compliance costs, and ROI potential for implementing advanced biosecurity and disease monitoring systems.
    • Diagnostic Equipment Manufacturers : Companies developing poultry diagnostic solutions require North America-specific market insights to guide R&D priorities, pricing strategies, and market entry decisions in this high-growth region.
    • Veterinary Service Providers : Veterinarians and diagnostic laboratories serving North American poultry farms need market data to assess service demand, justify equipment investments, and plan capacity expansion.
    • Investment & Private Equity Firms : Investors evaluating opportunities in animal health diagnostics require validated market sizing and growth projections for North America to assess portfolio companies and identify acquisition targets.
    • Regulatory & Policy Bodies : Government agencies and agricultural organizations use market data to inform biosecurity policy development, funding allocation, and disease prevention initiatives across North American poultry sectors.

    Key Companies in the North America Poultry Diagnostics Market

    CompanyHQOwnershipStrongest segments
    COSMO BIO CO LTDJapanPublic CompanyReagents, Antibodies, and Bioactive Substances,Cell and Tissue Culture Products,Research Instruments and Labware,
    PATTERSON COMPANIES, INCUnited StatesPrivate CompanyDental consumables, equipment, and practice optimization solutions,Animal Health distribution and private label brands,Corporate and customer financing services,
    IDEXX LABORATORIES, INC.United StatesPublic CompanyCompanion Animal Group (in-clinic analyzers, SNAP assays, reference labs, telemedicine, software),Livestock, Poultry and Dairy Diagnostics,Water Quality Products,
    THERMO FISHER SCIENTIFIC INC.United StatesPublic CompanyLife Sciences Solutions,Analytical Instruments,Specialty Diagnostics,
    BIONOTESouth KoreaPublic CompanyVeterinary fluorescence immunoassay and analyzers,Veterinary clinical biochemistry systems,Veterinary rapid immunoassay and ELISA kits,
    BIO-RAD LABORATORIES, INC.United StatesPublic CompanyClinical Diagnostics systems, kits, and quality controls,Life Science research instruments and reagents,Informatics, software, and other,
    GDUnited StatesPublic CompanyAerospace (Gulfstream and services),Marine Systems (submarines and surface ships),Combat Systems (land combat and munitions),
    SHENZHEN BIOEASY BIOTECHNOLOGY, INC.ChinaPublic CompanyRapid test kits (veterinary, melamine, mycotoxin, pesticide, adulteration, ATP, vitamin),Instruments and equipment (incubators, readers, suitcase labs, automatic pressers),Materials (pretreatment columns, certified reference materials, quality control),

    COSMO BIO CO LTD

    Cosmo Bio Co Ltd is a Japanese public company founded in 1978 with 182 employees, operating in the bioscience sector.

    PATTERSON COMPANIES, INC

    Patterson Companies, Inc. is a United States-based private company founded in 1877 with 7,600 employees, operating as a major distributor in the healthcare and life sciences sectors.

    IDEXX LABORATORIES, INC.

    IDEXX Laboratories, Inc. is a United States-based public company founded in 1983 with 11,000 employees, specializing in diagnostic and software solutions for veterinary and life sciences markets.

    THERMO FISHER SCIENTIFIC INC.

    Thermo Fisher Scientific Inc. is a United States-based public company founded in 1956 with 125,000 employees, serving as a global leader in life sciences, analytical instruments, and laboratory services.

    BIONOTE

    Bionote is a South Korean public company founded in 2003 with 298 employees, operating in the bioscience and diagnostics industry.

    BIO-RAD LABORATORIES, INC.

    Bio-Rad Laboratories, Inc. is a United States-based public company founded in 1952 with 7,450 employees, specializing in life science research and clinical diagnostics products.

    GD

    GD is a United States-based public company founded in 1899 with 117,000 employees operating across multiple industrial and commercial sectors.

    SHENZHEN BIOEASY BIOTECHNOLOGY, INC.

    Shenzhen Bioeasy Biotechnology, Inc. is a Chinese public company founded in 2007 with 542 employees, operating in the biotechnology and diagnostics sector.

    North America vs. other regions

    HowNorth America compares to the other 3 regional blocs covered in this market.

    Europe
    ~USD 63.1 Million · 6.4% wtd CAGR ·
    Asia Pacific
    ~USD 65.8 Million · 8.6% wtd CAGR ·
    Latin America
    ~USD 13.1 Million · 6.1% wtd CAGR ·
    Middle East & Africa
    ~USD 3.2 Million · 4.4% wtd CAGR ·

    Countries within North America - compare and drill down

    Country2025 size (native)
    USUSD 104.72 Million
    CanadaUSD 2.31 Million

    Country market size visualization

    US
    USD 104.72 Million
    Canada
    USD 2.31 Million

    Reasons to Buy this Report

    • Market Size & Growth Validation : Obtain precise market valuation for North America ($76.7M in 2026) and verified forecast data through 2031, enabling accurate business planning and investment decisions specific to this high-value region.
    • Regulatory Landscape Intelligence : Understand stringent biosecurity regulations and disease surveillance mandates across the US and Canada that are driving diagnostic adoption, helping you align product development with compliance requirements.
    • Country-Level Market Breakdown : Access detailed market data for the US ($104.72M) and Canada ($2.31M), allowing targeted go-to-market strategies and resource allocation based on regional market dynamics.
    • Technology Adoption Trends : Identify emerging diagnostic technologies gaining traction in North American poultry operations, including molecular diagnostics and real-time monitoring systems, to inform product innovation strategies.
    • Competitive Positioning : Benchmark your offerings against market growth rates and identify white space opportunities in North America's rapidly evolving poultry diagnostics landscape through comprehensive regional analysis.

    Frequently asked questions

    What is the current size of North America's poultry diagnostics market?

    North America's poultry diagnostics market is estimated at $76.7 million in 2026.

    What is the projected market size for North America by 2031?

    North America's poultry diagnostics market is forecast to reach $107.0 million by 2031.

    What is the CAGR for North America's poultry diagnostics market?

    North America's poultry diagnostics market is expected to grow at a compound annual growth rate of 6.9% from 2026 to 2031.

    What factors are driving growth in North America's poultry diagnostics market?

    Growth in North America is driven by stringent biosecurity regulations, disease surveillance requirements, advanced diagnostic technology adoption, and consumer demand for safe poultry products.

    Which diagnostic technologies are gaining traction in North America?

    North America is seeing increased adoption of molecular diagnostics, immunological platforms, and point-of-care diagnostic systems for rapid disease detection.

    RESEARCH METHODOLOGY

    This research study extensively utilized both primary and secondary sources. It involved analyzing various factors influencing the industry to identify segmentation types, industry trends, key players, the competitive landscape, key market dynamics, and strategies employed by key players.

    Secondary Research

    This research study utilized a variety of comprehensive secondary sources, including directories, databases such as Bloomberg Business, Factiva, and Dun & Bradstreet, white papers, annual reports, company house documents, investor presentations, and SEC filings from various companies. Secondary research was employed to gather information crucial for an in-depth, technical, market-oriented, and commercial analysis of the poultry diagnostics market. This approach also helped identify key players in the industry and allowed for classification and segmentation based on emerging trends at the most detailed level. Furthermore, significant developments pertaining to both market and technological perspectives were documented. A database of primary industry leaders was created as part of this secondary research.

    Primary Research

    In the primary research process, we interviewed a range of sources from both the supply and demand sides to gather qualitative and quantitative information for this report. Primary sources from the supply side include project/sales/marketing/business development managers, presidents, CEOs, vice presidents, chairpersons, chief operating officers, chief strategy officers, directors, chief information officers, and chief medical information officers related to the poultry diagnostics market. Primary sources from the demand side include poultry veterinarians, managers of commercial poultry farms and integrators, directors of veterinary diagnostic laboratories, officials from government animal health agencies, and procurement and purchasing teams.

    Breakdown of Primary Respondents:

    Poultry Diagnostics Market

    Note 1: C-level executives include CEOs, COOs, CTOs, and VPs.

    Note 2: Other designations include sales, marketing, and product managers.

    Note 3: Tiers are defined based on a company’s total revenue. As of 2025: Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = < USD 500 million.

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    The total size of the poultry diagnostics market was determined after data triangulation from three approaches, as mentioned below. After each approach, the weighted average of the three approaches was taken based on the level of assumptions used in each approach.

    Poultry Diagnostics Market

    Data Triangulation

    After arriving at the market size, the total market was divided into several segments and subsegments. Data triangulation and market breakdown procedures were employed wherever applicable to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.

    Market Definition

    The poultry diagnostics market comprises products and services used for the detection, identification, and monitoring of infectious diseases in poultry species, including broilers, layers, and breeders. It includes diagnostic kits, reagents, consumables, instruments, and laboratory services based on technologies such as PCR, ELISA, rapid immunoassays, and other molecular and serological methods. These solutions are utilized by veterinary diagnostic laboratories, commercial poultry producers, research institutions, and government agencies for routine surveillance, outbreak confirmation, biosecurity compliance, and export certification. The market supports early disease detection, flock health management, and control of transboundary and endemic poultry diseases.

    Stakeholders

    • Poultry diagnostic kit manufacturers (ELISA, PCR, rapid tests)
    • Molecular technology providers & instrument manufacturers
    • Reagent & consumable suppliers
    • Veterinary diagnostic laboratories (private & public)
    • Government animal health authorities & surveillance agencies
    • Integrated poultry producers & commercial farms
    • Poultry veterinarians & technical service providers
    • Academic & veterinary research institutions
    • Contract manufacturers & OEM partners
    • Distributors & regional channel partners
    • Market research & consulting firms
    • Investors & venture capital firms

    Report Objectives

    • To define, describe, segment, and forecast the poultry diagnostics market by product type, test type, disease type, poultry type, sample type, end user, and region
    • To provide detailed information about the factors influencing market growth (such as drivers, restraints, opportunities, and challenges)
    • To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall poultry diagnostics market
    • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
    • To forecast the size of the poultry diagnostics market in five main regions (along with their respective key countries): North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
    • To profile the key players in the poultry diagnostics market and comprehensively analyze their core competencies and market shares
    • To track and analyze competitive developments such as acquisitions, product launches, expansions, collaborations, agreements, and partnerships

    Get the Full Poultry Diagnostics Market Report

    Full forecast, segment splits, and company analysis for all Poultry Diagnostics Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status